2017
DOI: 10.1016/j.phymed.2017.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Molecular targets and anticancer potential of sanguinarine—a benzophenanthridine alkaloid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
46
0
5

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(62 citation statements)
references
References 146 publications
1
46
0
5
Order By: Relevance
“…As shown in Figure 3, SC treatment reduced 49.75% of wound closure rate compared to the untreated group, which is consistent with the tube formation assay. Our results are in line with the earlier study where SC exhibited a significantly anti-angiogenic effect in various kinds of tumors (Gaziano et al, 2016;Galadari et al, 2017).…”
Section: Inhibition Of Human Retinal Microvascular Endothelial Cells supporting
confidence: 93%
See 1 more Smart Citation
“…As shown in Figure 3, SC treatment reduced 49.75% of wound closure rate compared to the untreated group, which is consistent with the tube formation assay. Our results are in line with the earlier study where SC exhibited a significantly anti-angiogenic effect in various kinds of tumors (Gaziano et al, 2016;Galadari et al, 2017).…”
Section: Inhibition Of Human Retinal Microvascular Endothelial Cells supporting
confidence: 93%
“…One of the promising candidate is Sanguinarine Chloride (SC) (Mackraj et al, 2008;Basu and Kumar, 2016), a benzo phenanthridine alkaloid derived from the root of Sanguinaria Canadensis and other poppy-fumaria species, which has been proved to exert anti-tumor properties due to its anti-proliferation, antiangiogenic and anti-invasive properties in various preclinical studies (Gaziano et al, 2016;Achkar et al, 2017). Specifically, SC could inhibit angiogenesis of cancer cells via blocking VEGF-induced vessel growth, cell migration, sprouting, and survival (Galadari et al, 2017;Xu et al, 2012;Eun and Koh, 2004;Basini et al, 2007a;Basini et al, 2007c). As the fact that neovascular vessels built in ocular diseases has the similar pathology features with tumor, which are all built to compensate for the lack of oxygen (Hennig and Goepferich, 2015), we hypothesed that SC might also be a suitable antiangiogenic treatment for ocular neovascular diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Sanguinarine, a benzophenanthridine alkaloid, exhibits broad‐spectrum anticancer activities, but little attention has been paid to its effects on hypoxia‐induced breast cancer progression in breast cancers.…”
Section: Introductionmentioning
confidence: 99%
“…The most intensively investigated of these is the anticancer activity of sanguinarine and berberine. Many pieces of evidence indicate that sanguinarine inhibits cell cycle and induce apoptosis in various types of cancer cells [19,20]. Sanguinarine induces apoptosis in receptor [21] and mitochondrial pathways [21,22,23,24].…”
Section: Introductionmentioning
confidence: 99%